Wednesday, June 10, 2026
🇺🇸 FDA

Intelligence · INN directory

Pharmaceutical Drugs

Regulatory status, brand names, and pipeline context for BD, medical affairs, and competitive intelligence teams.

Drugs indexed 4,797
Companies 1,769
Pipeline programs 20,548

Quick answer

NovaPharmaNews tracks 4,797 pharmaceutical drugs by INN (International Nonproprietary Name), with US FDA approval status, brand names, originators, routes of administration, and links to pipeline programs and patents. Search by generic name or browse A–Z for competitive intelligence and medical affairs reference.

Recently updated

FDA-approved

Showing page 87 of 200 · By data quality, then INN

  1. nalidixic acid

    NALIDIXIC ACID

    ORAL FDA: approved

  2. naloxegol

    MOVENTIG

    ORAL FDA: approved · EMA: approved

    A06AH03

  3. naloxegol oxalate

    MOVANTIK

    ORAL FDA: approved

  4. nandrolone phenpropionate

    NANDROLONE PHENPROPIONATE

    INJECTION FDA: approved

  5. naphazoline hydrochloride

    ALBALON

    OPHTHALMIC FDA: approved

  6. naratriptan hydrochloride

    NARATRIPTAN

    ORAL FDA: approved

  7. natalizumab

    TYSABRI Biogen

    SINGLE-USE FDA: approved · EMA: approved · TGA: approved

    L04AG03

  8. natalizumab-sztn

    TYRUKO

    INJECTION FDA: approved

  9. natamycin

    NATACYN

    OPHTHALMIC FDA: approved

  10. navepegritide

    YUVIWEL

    SUBCUTANEOUS FDA: approved

  11. naxitamab-gqgk

    DANYELZA

    INTRAVENOUS FDA: approved

  12. nebivolol hydrochloride

    NEBIVOLOL HYDROCHLORIDE

    ORAL FDA: approved

  13. necitumumab

    PORTRAZZA

    INTRA-ARTICULAR, INTRAMUSCULAR, INTRAVITREAL FDA: approved · EMA: withdrawn

    L01

  14. nedocromil sodium

    TILADE

    OPHTHALMIC FDA: approved

  15. nedosiran sodium

    RIVFLOZA

    INJECTION FDA: approved

  16. nelfinavir mesylate

    VIRACEPT

    ORAL FDA: approved

  17. nemolizumab-ilto

    NEMLUVIO

    INJECTION FDA: approved

  18. nepafenac

    NEVANAC

    OPHTHALMIC FDA: approved · EMA: approved

    S01BC10

  19. nerandomilast

    JASCAYD

    ORAL FDA: approved · EMA: unknown

  20. nesiritide

    NATRECOR

    INTRAVENOUS FDA: approved

  21. netarsudil

    RHOKIINSA

    DROPS FDA: approved · EMA: approved

    S01EX05

  22. netarsudil mesylate

    RHOPRESSA

    OPHTHALMIC FDA: approved

  23. netilmicin sulfate

    NETROMYCIN

    INJECTION FDA: approved

  24. netupitant

    AKYNZEO

    ORAL FDA: approved · EMA: approved

    A04AA

Frequently asked questions

What is the NovaPharmaNews drugs directory?

It is a searchable index of 4,797 pharmaceutical active ingredients and their marketed profiles — INN, brand names, US regulatory status, manufacturers, and cross-links to clinical pipeline and patent records.

Where does drug approval data come from?

Profiles combine FDA Drugs@FDA and Orange Book references, ClinicalTrials.gov pipeline links, and editorial enrichment. See our data sources page for attribution and update cadence. This directory is for professional reference, not medical advice.

How do I find a drug by brand name?

Use the search box on this page — it matches both INN (generic name) and slug. Brand names appear on each drug row and on the full drug profile page, with links to the originator company when available.

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.